Original articleBioisosteric replacement of an acylureido moiety attached to an indolin-2-one scaffold with a malonamido or a 2/4-pyridinoylamido moiety produces a selectively potent Aurora-B inhibitor

Add time:08/27/2019    Source:sciencedirect.com

Bioisosteric replacement of acylureido moiety in 6-acylureido-3-pyrrolylmethylidene-2-oxoindoline derivatives resulted in a series of malonamido derivatives with indolin-2-one scaffold (11–14). Further conformational restrictions of the malonamido moiety led to 2-oxo-1,2-dihydropyridine (21–25) or a 4-oxo-1,4-dihydropyridine derivatives (31–36). 4-Oxo-1,4-dihydropyridine derivatives were more potent Aurora B inhibitors than their 2-oxo-1,2-dihydropyridine counterparts and demonstrated cytotoxicities against A549 and HepG2 cells in the submicromolar range. In A549 cells, 31h decreased phosphorylation of histone H3, triggered polyploidy, induced expression of pro-apoptotic Fas and FasL with subsequent activation of caspase 8, resulting into apoptosis. In a Huh7-xenograft mouse model, 31h demonstrated potent in vivo efficacy with a daily dose of 5 mg/kg.

We also recommend Trading Suppliers and Manufacturers of 3-AMINOINDOLIN-2-ONE (cas 117069-75-7). Pls Click Website Link as below: cas 117069-75-7 suppliers

Prev:Research paper1-Aroylindoline-hydroxamic acids as anticancer agents, inhibitors of HSP90 and HDAC
Next:Original articleSynthesis and antimycobacterial screening of new N-(4-(5-aryl-3-(5-methyl-1,3,4-oxadiazol-2-yl)-1H-pyrazol-1-yl)phenyl)-4-amide derivatives)